Variability of Coronary Physiology (FFR/iFR) in Diffuse Tandem Lesions

Physiology guided revascularization has been shown to improve clinical outcomes vs. conventional angiography. However, after percutaneous coronary intervention (PCI) residual pressure gradients may persist, and multiple studies have linked these to persistent angina. This is why adequate physiological assessment is required, both before and after procedure. 

The physiological assessment of coronary artery disease (CAD) has evolved from evaluating the hemodynamic severity of single stenosis lesions to more comprehensive, longitudinal pressure mapping using pullback. This technique will anticipate revascularization impact on serial or diffuse disease (with pressure drift presence). However, the predictive value of translesional pressure gradients (ΔFFR o ΔiFR) had not been systematically assessed so far. 

The SERIAL was a randomized multicenter trial carried out in four UK centers including 87 patients with at least one significant focal lesion and a second one or a diffusely diseased segment in the same vessel. Participates were randomized 1:1 to FFR or iFR guided PCI. They all underwent pre and post-PCI pullback assessment, mainly to assess the difference between predicted post-PCI ΔFFR or ΔiFR value vs real post intervention ΔFFR or ΔiFR value. As secondary outcome, the study looked at predictive accuracy of FFRcalc model (a formula accounting for lesion interaction).  

Mean patient age was 67, 31% had diabetes and 74% presented stable angina. The most frequently assessed artery was the anterior descending (64%). Mean baseline FFR and iFR values were 0.71 and 0.82 respectively, with 13% discordance.

Read also: NAVULTRA Registry: One-Year Outcomes of Self-Expanding vs. Balloon-Expandable Valves.

It was shown that both ΔFFR and ΔiFR systematically overestimated the hemodynamic benefit of treating one single target lesion. Mean prediction error was 12% for FFR and 4% for iFR (p<0.001). Also, applying ischemia binary thresholds (FFR ≤ 0.80, iFR ≤ 0.89) resulted in misclassification of residual ischemia in over one third of cases (36% and 34%, respectively). The use of the FFRcalc new parameter reduced error margin (14% misclassification), though it tended to underestimate the benefit and showed greater variability upon serial assessment. 

These findings from a randomized design challenge the value of pullback pressure gradient as a reliable, sole predictive tool, especially in common scenarios such as serial of diffuse CAD. 

Conclusion

The SERIAL, first head-to-head trial on diffuse lesions, has shown predicting post-PCI physiological outcomes using ΔFFR or ΔiFR in serial disease is inaccurate due to overestimation. FFRcalc might offer better diagnostic performance; however, the safest strategy still is post intervention physiological assessment. 

Original Title: Randomized Comparison of Fractional Flow Reserve and Instantaneous Wave Free Ratio in Serial Disease.

Reference: Li Kam Wa, M, Ezad, S, Modi, B. et al. Randomized Comparison of Fractional Flow Reserve and Instantaneous Wave Free Ratio in Serial Disease. J Am Coll Cardiol Intv. 2025 Jul, 18 (13) 1617–1627. https://doi.org/10.1016/j.jcin.2025.05.033.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Omar Tupayachi
Dr. Omar Tupayachi
Member of the Editorial Board of solaci.org

More articles by this author

Drugs for the Treatment of No-Reflow During PCI

The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

Rotational atherectomy and its technical secrets: use of floppy or ES guidewire

Rotational atherectomy (RA) remains a very useful tool in the management of severe coronary calcification. However, many of its technical aspects rely more on...

CRT 2026 | CUT-DRESS Trial: Lesion Preparation with Cutting Balloon

In-stent restenosis (ISR) continues to represent a relevant clinical challenge in contemporary coronary angioplasty practice. Despite advances in drug-eluting stents, neointimal hyperplasia and suboptimal...

CRT 2026 | Clopidogrel vs Aspirin as Long-Term Monotherapy After Coronary Angioplasty

The use of aspirin as chronic antiplatelet therapy after percutaneous coronary intervention (PCI) has historically been the standard recommended by international guidelines. However, recent...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Drugs for the Treatment of No-Reflow During PCI

The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

Coronary revascularization before TAVI: prior PCI or conservative management?

The coexistence of coronary artery disease (CAD) in patients with severe aortic stenosis undergoing TAVI is common, with a reported prevalence ranging from 30%...

Rotational atherectomy and its technical secrets: use of floppy or ES guidewire

Rotational atherectomy (RA) remains a very useful tool in the management of severe coronary calcification. However, many of its technical aspects rely more on...